Home » Topics » Regulatory » Patents

Patents
RSS

Thrombopoietin receptor (TPOR) activators disclosed by Nissan Chemical

Feb. 16, 2005

Antibacterial prodrugs of 6-beta-hydroxymethylpenicillanic acid sulfone claimed in Pfizer patent

Feb. 16, 2005

New humanized anti-beta amyloid peptide monoclonal antibodies jointly reported by Neuralab and Wyeth

Feb. 15, 2005

Novel NMDA/NR2B antagonists discovered at Merck

Feb. 15, 2005

FibroGen claims new hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors

Feb. 15, 2005

Five series of Src tyrosine kinase inhibitors reported by AstraZeneca

Feb. 15, 2005

Novel cannabinoid CB1 receptor agonists claimed by AstraZeneca

Feb. 15, 2005

Metabotropic glutamate (mGluR5) receptor antagonists described in patent literature

Feb. 14, 2005

Novel antiinflammatory chalcones patented by AtheroGenics

Feb. 14, 2005

Bristol-Myers Squibb patent covers new antiinflammatory agents

Feb. 14, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...